Tofacitinib (CP-690.550) |
Influence on Th1 differentiation |
Intracellular staining |
10.00 nM |
Naïve CD4+ T |
Mus musculus |
c57BL/6 |
|
|
Tofacitinib (CP-690.550) |
Influence on Th1 differentiation |
Intracellular staining |
50.00 nM |
Naïve CD4+ T |
Mus musculus |
c57BL/6 |
|
|
Tofacitinib (CP-690.550) |
Influence on Th2 differentiation |
Intracellular staining |
10.00 nM |
Naïve CD4+ T |
Mus musculus |
c57BL/6 |
|
|
Tofacitinib (CP-690.550) |
Influence on Th2 differentiation |
Intracellular staining |
50.00 nM |
Naïve CD4+ T |
Mus musculus |
c57BL/6 |
|
|
Tofacitinib (CP-690.550) |
Influence on Th17 differentiation |
Intracellular staining |
10.00 nM |
Naïve CD4+ T |
Mus musculus |
c57BL/6 |
|
|
Tofacitinib (CP-690.550) |
Influence on Th17 differentiation |
Intracellular staining |
50.00 nM |
Naïve CD4+ T |
Mus musculus |
c57BL/6 |
|
|
Tofacitinib (CP-690.550) |
Influence on Th17 differentiation |
Intracellular staining |
10.00 nM |
Naïve CD4+ T |
Mus musculus |
c57BL/6 |
|
|
Tofacitinib (CP-690.550) |
Influence on Th17 differentiation |
Intracellular staining |
100.00 nM |
Naïve CD4+ T |
Mus musculus |
c57BL/6 |
|
|